Related Experiment Video
Updated: Apr 14, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Deletion of histone deacetylase 7 in osteoclasts decreases bone mass in mice by interactions with MITF
Melissa Stemig1, Kristina Astelford2, Ann Emery1
1Department of Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, Minnesota, United States of America.
Abstract:
Molecular regulators of osteoclast formation and function are an important area of research due to the central role of osteoclasts in bone resorption. Transcription factors such as MITF are essential for osteoclast generation by regulating expression of the genes required for cellular differentiation and resorptive function. We recently reported that histone deacetylase 7 (HDAC7) binds to and represses the transcriptional activity of MITF in osteoclasts, and that loss of HDAC7 in vitro accelerated osteoclastogenesis. In the current study, we extend this initial observation by showing that conditional deletion of HDAC7 in osteoclasts of mice leads to an in vivo enhancement in osteoclast formation, associated with increased bone resorption and lower bone mass. Expression of multiple MITF target genes is increased in bone marrow derived osteoclast cultures from the HDAC7 knockout mice. Interestingly, multiple regions of the HDAC7 amino-terminus can bind to MITF or exert repressive activity. Moreover, mutation or deletion of the HDAC7 conserved deacetylase catalytic domain had little effect on repressive function. These observations identify HDAC7 in osteoclasts as an important molecular regulator of MITF activity and bone homeostasis, but also highlight a gap in our understanding of exactly how HDAC7 functions as a corepressor.
Insights
Histone deacetylase 7 (HDAC7) normally limits osteoclast formation. Removing HDAC7 in mice boosts osteoclast activity, increasing bone resorption and decreasing bone mass.
Area of Science:
- Molecular biology
- Bone biology
- Cellular regulation
Background:
- Osteoclasts are key to bone resorption.
- Transcription factors like MITF control osteoclast differentiation.
- HDAC7 was previously found to repress MITF activity in vitro.
Purpose of the Study:
- To investigate the in vivo role of HDAC7 in osteoclast biology.
- To determine the effect of HDAC7 deletion on bone homeostasis.
- To elucidate the mechanism of HDAC7-mediated MITF repression.
Main Methods:
- Conditional deletion of HDAC7 in mouse osteoclasts.
- Analysis of bone mass and microarchitecture in vivo.
- Assessment of osteoclast formation and gene expression in vitro.
Main Results:
- Conditional deletion of HDAC7 in osteoclasts increased osteoclast formation and bone resorption in vivo.
- HDAC7 knockout mice exhibited reduced bone mass.
- Expression of MITF target genes was upregulated in HDAC7-deficient osteoclasts.
- HDAC7's amino-terminus binds MITF and represses its activity, independent of its catalytic domain.
Conclusions:
- HDAC7 is a critical regulator of MITF activity and bone homeostasis in vivo.
- Loss of HDAC7 enhances osteoclastogenesis and leads to lower bone mass.
- HDAC7 functions as a repressor of MITF, but the precise mechanism remains unclear.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

